Kbc Group Nv Sarepta Therapeutics, Inc. Transaction History

Kbc Group Nv

$37 Billion
Q2 2025

A detailed history of Kbc Group Nv transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 3,152 shares of SRPT stock, worth $59,289. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,152

Previous 3,695 14.7%

Holding current value

$59,289

Previous $236,000 77.12%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$17.1 - $63.66 $9,285 - $34,567	-543 Reduced 14.7%	3,152 $54,000
Q1 2025 Apr 25, 2025	SELL	$63.82 - $127.89 $319 - $639	-5 Reduced 0.14%	3,695 $236,000
Q4 2024 Jan 22, 2025	BUY	$104.54 - $137.94 $142,278 - $187,736	1,361 Added 58.19%	3,700 $450,000
Q3 2024 Nov 06, 2024	BUY	$124.33 - $156.75 $29,590 - $37,306	238 Added 11.33%	2,339 $292,000
Q2 2024 Jul 17, 2024	BUY	$113.33 - $163.85 $19,606 - $28,346	173 Added 8.97%	2,101 $332,000

Q1 2024 May 08, 2024	BUY	$93.7 - $141.53 $41,977 - $63,405	448 Added 30.27%	1,928 $250,000
Q4 2023 Feb 13, 2024	BUY	$67.31 - $124.76 $99,618 - $184,644	1,480 New	1,480 $143,000
Q4 2021 Feb 03, 2022	SELL	$77.28 - $99.42 $42,890 - $55,178	-555 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$65.97 - $92.48 $418,711 - $586,970	-6,347 Reduced 91.96%	555 $51,000
Q2 2021 Aug 11, 2021	SELL	$69.38 - $86.75 $2,567 - $3,209	-37 Reduced 0.53%	6,902 $536,000
Q3 2020 Oct 28, 2020	SELL	$127.12 - $172.34 $393,563 - $533,564	-3,096 Reduced 30.85%	6,939 $975,000
Q2 2020 Aug 10, 2020	BUY	$93.0 - $171.7 $190,650 - $351,985	2,050 Added 25.67%	10,035 $1.61 Million
Q1 2020 May 04, 2020	BUY	$82.38 - $131.64 $209,574 - $334,892	2,544 Added 46.76%	7,985 $781,000
Q4 2019 Feb 11, 2020	BUY	$76.53 - $135.58 $255,686 - $452,972	3,341 Added 159.1%	5,441 $702,000
Q3 2019 Nov 07, 2019	BUY	$72.81 - $156.91 $108,122 - $233,011	1,485 Added 241.46%	2,100 $158,000
Q2 2019 Dec 03, 2019	BUY	$112.21 - $151.95 $69,009 - $93,449	615 New	615 $93,000
Q2 2019 Jul 30, 2019	SELL	$112.21 - $151.95 $69,009 - $93,449	-615 Closed	0 $0
Q1 2019 Dec 03, 2019	BUY	$106.67 - $151.68 $65,602 - $93,283	615 New	615 $73,000

Others Institutions Holding SRPT

# of Institutions

406

Shares Held

83.7M

Call Options Held

5.27M

Put Options Held

5.94M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.65B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account